论文部分内容阅读
试验的目的是研究Pravastatin降低低密度脂蛋白(LDL)胆固醇的浓度,能否延缓动脉粥样硬化的进展。 方法 临床试验开始于1987年,为期3年,双盲、安慰剂对照、随机分组,受试对象为151例冠心病患者,采用超声测定颈动
The purpose of the trial was to investigate whether Pravastatin reduces the level of low-density lipoprotein (LDL) cholesterol and slows the progression of atherosclerosis. Methods Clinical trials began in 1987 with a 3-year, double-blind, placebo-controlled trial of 151 patients with coronary heart disease who underwent carotid artery ultrasonography